CALIFORNIA: Drugs Help AIDS Patients Live Well into Senior Years

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

CALIFORNIA: Drugs Help AIDS Patients Live Well into Senior Years

Daily News of Los Angeles (12.01.05) - Wednesday, December 07, 2005
Rachel Uranga

Experts predict that in the coming decade, more AIDS patients will join the ranks of seniors, thanks to drug treatments that extend their lives. The proportion of Los Angeles County residents with AIDS age 50 and older has grown from 14 percent in 1997 to more than 25 percent in 2004. About 6 percent are 60 or older.

"We will often joke in the clinic that the least of a person's problems is HIV," said Eric Daar, chief of HIV medicine at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. "Their viral counts may be low, but they have diabetes or high blood pressure."

Doctors are concerned that they are only now beginning to learn the long-term side effects of AIDS drug cocktails. "This is really new territory," said Michael Montgomery, head of the Office of AIDS for the California Department of Health Services. "Antiretroviral drugs are highly toxic medications, and we seem to be seeing problems with heart disease and other illnesses."

The cost of AIDS treatment rises with a person's age. The state's average cost for treating patients ages 51-60 is $9,007 per year, compared with $7,609 for patients ages 18-30. After age 60, the average per-patient cost to the state is $9,421 per year. Currently, 44 percent of Los Angeles residents with AIDS are ages 40-49.
051207
AD052463

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.